Global Market: European shares climb as earnings, US-Iran diplomacy lift sentimentEuropean stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...
ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...
Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
Novartis to spin off generics biz sandozThe company started a strategic review of Sandoz last October - examining a range of options, including retaining the business, spinning it...
Aurobindo Pharma aims to become debt free in 3 years sans Sandoz dealIn September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations ...
Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
Biocon teams up with Swiss drugmaker Sandoz for next gen biosimilarUnder the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...
Biocon teams up with Sandoz for next-gen BiosimilarsBiosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.
Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
Sandoz gets US FDA warning letter for Turbhe, Kalwe sitesThe observations in the warning letter dated October 22 are related to deficiencies in current good manufacturing practice (cGMP) for finis...
Sandoz gets warning letter for Turbhe, Kalwe siteSandoz, the generic drug arm of Swiss giant Novartis, has received a warning letter from the US FDA on October 22 for its two Indian sites ...
Cipla gains as partner Sandoz gets USFDA approval for generic drugCipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.
Sandoz Inc recalls India-made anti-allergic tablets in USDrug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...